Recombinant multi-species AURKA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AURKA protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a cell cycle-regulated kinase that appears to be involved in microtubule formation and/or stabilization at the spindle pole during chromosome segregation. The encoded protein is found at the centrosome in interphase cells and at the spindle poles in mitosis. This gene may play a role in tumor development and progression. A processed pseudogene of this gene has been found on chromosome 1, and an unprocessed pseudogene has been found on chromosome 10. Multiple transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: AIK,AIRK1,ARK-1,ARK1,AURA,AURKA,Ark1,Aurka,Aurora 2,Aurora kinase A,Aurora-A,Aurora-related kinase 1),Aurora/IPL1-related kinase 1 (ARK-1,Ayk1,BTAK,Breast tumor-amplified kinase,IAK,IAK1,Ipl1- and aurora-related kinase 1,PPP1R47,STK15,STK6,STK7,Serine/threonine-protein kinase 15,Serine/threonine-protein kinase 6,Serine/threonine-protein kinase Ayk1,Serine/threonine-protein kinase aurora-A,Stk6

Target products collectionGo to AURKA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T87675-Ag-1/ GM-Tg-hg-T87675-Ag-2 Human AURKA protein Human
GM-Tg-rg-T87675-Ag-1/ GM-Tg-rg-T87675-Ag-2 Rat AURKA protein Rat
GM-Tg-mg-T87675-Ag-1/ GM-Tg-mg-T87675-Ag-2 Mouse AURKA protein Mouse
GM-Tg-cynog-T87675-Ag-1/ GM-Tg-cynog-T87675-Ag-2 Cynomolgus/Rhesus macaque AURKA protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T87675-Ag-1/ GM-Tg-felg-T87675-Ag-2 Feline AURKA protein Feline
GM-Tg-cang-T87675-Ag-1/ GM-Tg-cang-T87675-Ag-2 Canine AURKA protein Canine
GM-Tg-bovg-T87675-Ag-1/ GM-Tg-bovg-T87675-Ag-2 Bovine AURKA protein Bovine
GM-Tg-equg-T87675-Ag-1/ GM-Tg-equg-T87675-Ag-2 Equine AURKA protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T87675-Ag-1/ GM-Tg-hg-T87675-Ag-2; GM-Tg-rg-T87675-Ag-1/ GM-Tg-rg-T87675-Ag-2;
GM-Tg-mg-T87675-Ag-1/ GM-Tg-mg-T87675-Ag-2; GM-Tg-cynog-T87675-Ag-1/ GM-Tg-cynog-T87675-Ag-2;
GM-Tg-felg-T87675-Ag-1/ GM-Tg-felg-T87675-Ag-2; GM-Tg-cang-T87675-Ag-1/ GM-Tg-cang-T87675-Ag-2;
GM-Tg-bovg-T87675-Ag-1/ GM-Tg-bovg-T87675-Ag-2; GM-Tg-equg-T87675-Ag-1/ GM-Tg-equg-T87675-Ag-2
Products Name AURKA protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name AURKA
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AURKA protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.